Core Viewpoint - The management measures for the use of raised funds by Jiangsu Lianhuan Pharmaceutical Co., Ltd. aim to standardize the usage and management of raised funds, enhance their effectiveness, and protect investors' rights [1]. Group 1: General Principles - The purpose of the management measures is to regulate the use and management of raised funds, improve their effectiveness, and protect investors' rights based on relevant laws and regulations [1]. - The term "raised funds" refers to funds raised through public and non-public securities issuance, excluding funds raised for equity incentive plans [1]. - "Excess raised funds" refers to the portion of actual net raised funds that exceeds the planned amount [1]. Group 2: Fund Storage - Raised funds must be stored in a special account approved by the board of directors, and cannot be used for non-raised fund purposes [4]. - A tripartite supervision agreement must be signed with the sponsor or independent financial advisor and the commercial bank within one month of the funds being received [4][5]. - The agreement must include details such as the account number, project details, and monthly bank statements [5]. Group 3: Fund Usage - The company must adhere to specific requirements when using raised funds, including clear regulations on application, approval, and disclosure procedures [11]. - Funds should primarily be used for main business operations and cannot be used for financial investments or to benefit related parties improperly [13]. - Any changes in the use of raised funds must be approved by the board and disclosed to shareholders [24][25]. Group 4: Supervision and Reporting - The company must maintain accurate records of fund usage and undergo quarterly internal audits [16]. - The board is required to conduct a comprehensive review of project progress and fund usage every six months, issuing a special report [32]. - Independent directors and the audit committee must continuously monitor the management and usage of raised funds [33]. Group 5: Excess Funds Management - Excess funds can be used for permanent working capital or repaying bank loans, with specific limits on the amount used [10][11]. - Any use of excess funds must be approved by the board and disclosed to shareholders, including the necessity and detailed plans for such use [11].
联环药业: 联环药业募集资金使用管理办法(2025年8月修订)